Invitae to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
Rhea-AI Summary
Invitae Corporation (NYSE: NVTA) announced its participation in the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021. The management team will engage in a fireside chat at 11:00 a.m. PT, while CEO Sean George will join the NGS Technologies panel at 1:00 p.m. PT. Interested investors can access live webcasts through the company’s investor relations site, with replays available shortly after the events. Invitae aims to integrate comprehensive genetic information into healthcare, enhancing test quality and accessibility.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, NVTA declined 7.29%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN FRANCISCO, Aug. 9, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in a fireside chat at the UBS Genomics 2.0 and MedTech Innovations Summit on Wednesday, August 11, 2021 at 11:00 a.m. PT and Sean George, chief executive officer of Invitae, will participate in the NGS Technologies panel presentation at 1:00 p.m. PT, both at Montage Laguna Beach.
The live webcasts of the fireside chat and the panel presentation may be accessed by visiting the investors section of the company website at ir.invitae.com. Replays of the webcasts will be available shortly after the conclusion of the fireside chat and panel presentation.
About Invitae
Invitae Corporation (NYSE: NVTA) is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company's website at invitae.com.
Contact:
ir@invitae.com
(628) 213-3369
View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-the-ubs-genomics-2-0-and-medtech-innovations-summit-301351402.html
SOURCE Invitae Corporation
FAQ
When is Invitae's participation in the UBS Genomics 2.0 and MedTech Innovations Summit?
What will Invitae's management team present at the UBS Summit?
How can investors access the live webcasts of Invitae's presentations?
What is the stock symbol for Invitae Corporation?
What is Invitae Corporation's mission?
